Brentuximab Intravenous and Kovaltry recombinant
Determining the interaction of Brentuximab Intravenous and Kovaltry recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Kovaltry (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-KPN Prenatal
- Brentuximab Intravenous-Krintafel
- Brentuximab Intravenous-Kristalose
- Brentuximab Intravenous-Kruschen Salts
- Brentuximab Intravenous-Krystexxa
- Brentuximab Intravenous-Kurvelo
- Kovaltry recombinant-Brentuximab vedotin
- Kovaltry recombinant-Breo Ellipta
- Kovaltry recombinant-Brethine
- Kovaltry recombinant-Brethine Subcutaneous
- Kovaltry recombinant-Bretylium
- Kovaltry recombinant-Bretylium Injection